Publisher
Springer Science and Business Media LLC
Subject
Radiology Nuclear Medicine and imaging,General Medicine,Radiology Nuclear Medicine and imaging,General Medicine
Reference10 articles.
1. Czepczynski R. Nuclear medicine in the diagnosis of benign thyroid diseases. Nucl Med Rev Cent East Eur. 2012;15:113–9.
2. Becker DV, Sawin CT. Radioiodine and thyroid disease: the beginning. Semin Nucl Med. 1996;26:155–64.
3. Kobe C, Eschner W, Wild M, Rahlff I, Sudbrock F, Schmidt M, et al. Radioiodine therapy of benign thyroid disorders: what are the effective thyroidal half-life and uptake of 131I? Nucl Med Commun. 2010;31:201–5.
4. Willegaignon J, Sapienza MT, Coura Filho GB, Traino AC, Buchpiguel CA. Determining thyroid (131)I effective half-life for the treatment planning of Graves’ disease. Med Phys. 2013;40:022502.
5. Berg GE, Michanek AM, Holmberg EC, Fink M. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements. J Nucl Med. 1996;37:228–32.